Skip to content

Remopharma

Active Private limited companyfounded 2008active for 18 yearsMeerdonkdorp 24, 9170 Sint-Gillis-WaasKBO/BCE: BE 0806.560.542 #8 company by equity in Sint-Gillis-Waas, Wholesale and retail trade sector

Annual accounts 2025

abbreviated format, filed on 18-08-2026, 18 days late
€1.1m
▲ 14.2%
€416,371
▼ 5.8%
€241,142
▼ 18.4%
€690,255
▼ 17.2%
60.2%
▲ 0.9 percentage points
1.83
▼ 0.49

Turnover is estimated at about €3.0m, probably between €2.2m and €4.1m. The abbreviated format does not state turnover.

Balance sheet

balance sheet total €3.7m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Position in the sector

60.2%

Higher than 74% of the 13,303 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

1.83

Higher than 59% of the 13,162 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

6.6%

Higher than 60% of the 13,223 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

Remopharma Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter · Staff: middle half

Staff

€65,124

Staff costs divided by the average number of full-time equivalents.

level

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023200916 months
622,368621,226616,547131,539
447,138474,889464,668100,741
503,456160,898157,581567,488
39,114-58,564--
690,255833,990637,19890,744
60.2%59.3%51.3%18.0%
1.832.321.851.48
1.221.531.231.05
0.660.690.954.56
10.9%15.1%18.2%15.9%
6.6%8.9%9.4%2.9%
5.5310.0610.08-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023200916 months
Balance sheet: assets
20/58 3.7m3.3m3.3m767,116
21/28 2.1m1.8m1.9m488,715
21 122,779148,179173,579208,000
22/27 2.0m1.7m1.7m280,715
22 1.2m1.1m1.2m196,296
23 843,549553,225488,769477
24 16,56218,25211,38083,942
29/58 1.5m1.5m1.4m278,401
3 507,696497,991464,97882,009
30/36 507,696497,991464,97882,009
40/41 333,208255,574277,14642,275
40 300,944220,225235,70839,468
41 32,26435,35041,4382,806
50/53 426,222501,222376,222-
54/58 233,124194,009252,574152,593
490/1 17,71814,74513,4871,525
Balance sheet: equity and liabilities
10/49 3.7m3.3m3.3m767,116
10/15 2.2m2.0m1.7m137,968
10/11 1,0001,0001,000116,000
100 ---116,000
13 2.2m2.0m1.7m21,968
130/1 --0-
130 ---11,600
1311 --0-
132 118118118-
133 2.2m2.0m1.7m10,368
17/49 1.5m1.3m1.6m629,148
17 629,311716,145831,724440,646
170/4 629,311716,145831,724440,646
42/48 827,712629,551747,208187,657
42 124,793132,755149,91336,080
44 628,904447,431499,07777,346
440/4 628,904447,431499,07777,346
45 73,89149,28098,0636,040
450/3 18,13811,00361,1056,040
454/9 55,75338,27736,958-
47/48 1258515568,191
492/3 1,2501,8323,452845
Income statement
9900 1.1m965,347932,226161,901
62 455,871329,855303,705-
630 205,996179,294160,54878,773
640/8 24,01114,26611,97430,363
9901 416,371441,932455,99952,766
75/76B 11,59614,5556,44131
75 11,59614,5556,44131
65/66B 112,54161,76861,16624,783
65 112,54161,76861,16624,783
9903 315,427394,719401,27428,013
67/77 74,28599,12497,1546,045
9904 241,142295,595304,12021,968
9905 241,142295,595304,12021,968
Appropriation of the result
9906 241,142295,595304,12021,968
691/2 241,142295,595304,12021,968
6920 ---11,600
6921 241,142295,595304,12010,368
Social balance sheet
9087 76.15.3-
Hours worked1013 12,2099,5289,221-
Document PDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 18-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 18-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00403475.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 18-08-2026 2026-00403475 PDF
31-12-2024 abbreviated format 28-08-2025 2025-00457910 PDF
31-12-2023 abbreviated format 28-08-2024 2024-00422752 PDF
31-12-2009 abbreviated format 07-07-2010 2010-29200530 PDF

Subsidies and aid

Flemish government 2024 to 2025, 2 entries, €3,340 awarded, €3,340 paid

Year Entries AwardedPaid
2025 1 €2,531€2,531
2024 1 €809€809

Social balance sheet

Item31-12-202531-12-202431-12-2023
Employees at the balance-sheet date997
full-time443
part-time554
in full-time equivalents76.85.8
76.15.3
On a permanent contract886
Joined264
Left244

Source: social balance sheet in the 2023 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item202520242023
Debts guaranteed by Belgian public bodies€754,104--

Source: notes to the 2023 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets€503,456€160,898€157,581
Financial fixed assets€0--
€205,996€179,294€160,548

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on Remopharma

The operating result for 2025 is 6% lower than in 2024 and the lowest since 2023. It is the second fall in a row.

Debt's share of the balance-sheet total falls from 40.7% to 39.8%. Equity and debt are higher.

Next steps